DOI QR코드

DOI QR Code

Diffuse large B-cell lymphoma presenting as transverse myelitis

  • Zukhriddin, Urchiyev (Department of Medicine, School of Medicine, Jeonbuk National University) ;
  • Kang, Jin-Ju (Department of Neurology, Jeonbuk National University Hospital, Jeonbuk National University School of Medicine) ;
  • Jeong, Myoung-Ja (Research Institute of Clinical Medicine of Jeonbuk National University-Jeonbuk National University Hospital) ;
  • Oh, Sun-Young (Department of Neurology, Jeonbuk National University Hospital, Jeonbuk National University School of Medicine)
  • Received : 2022.07.11
  • Accepted : 2022.08.03
  • Published : 2022.10.30

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Although progressive lymphadenopathy is a typical feature, extranodal involvement may also occur, including the gastrointestinal tract, skin, bone, thyroid, and testes. Central nervous system invasion is rare, so differentiating it from diseases such as inflammatory demyelinating disorder or infection is essential. DLBCL is therefore a challenge to diagnose, especially when the first findings are neurological symptoms. We report an unusual case of DLBCL that presented as transverse myelitis.

Keywords

Acknowledgement

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science and ICT) (No. 2022R1A2B5B01001933) and by the Biomedical Research Institute Fund, Jeonbuk National University Hospital.

References

  1. Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med 2021;384:842-858. https://doi.org/10.1056/NEJMra2027612
  2. Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology 2018;50:74-87.
  3. Shi Y, Han Y, Yang J, Liu P, He X, Zhang C, et al. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: analysis of 1,085 WHO classified cases in a single institution in China. Chin J Cancer Res 2019;31:152-161. https://doi.org/10.21147/j.issn.1000-9604.2019.01.10
  4. Chen Y, Lin C, Zhang B. Non-Hodgkin lymphoma with longitudinally extensive transverse myelopathy as the initial symptom: a case report. Front Oncol 2019;9:266. https://doi.org/10.3389/fonc.2019.00266
  5. Kim HS, Kim KK, Kim OJ. A case of diffuse large B-cell lymphoma presenting as transverse myelopathy. J Neurocrit Care 2008;1:177-180.
  6. Kumar N, Keegan BM, Rodriguez FJ, Hammack JE, Kantarci OH. Intravascular lymphoma presenting as a longitudinally-extensive myelitis: diagnostic challenges and etiologic clues. J Neurol Sci 2011;303:146-149. https://doi.org/10.1016/j.jns.2010.12.016
  7. Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004;127:173-183. https://doi.org/10.1111/j.1365-2141.2004.05177.x
  8. Frohman EM, Wingerchuk DM. Clinical practice. Transverse myelitis. N Engl J Med 2010;363:564-572. https://doi.org/10.1056/NEJMcp1001112
  9. Tolvaj B, Hahn K, Nagy Z, Vadvari A, Csomor J, Gelpi E, et al. Life threatening rare lymphomas presenting as longitudinally extensive transverse myelitis: a diagnostic challenge. Ideggyogy Sz 2020;73:275-285. https://doi.org/10.18071/ISZ.73.0275
  10. Yunoki M, Suzuki K, Uneda A, Yoshino K. A case of intravascular lymphoma presenting as myelopathy diagnosed with a skin biopsy. Surg Neurol Int 2015;6(Suppl 13):S367-S370.
  11. Merino A. Diffuse large B cell lymphoma presenting as transverse myelitis. Minn Med 2015;98:46.
  12. Shea L, Zhao Y, Reddy V, Yacoubian T, Mehta A. Primary bone marrow diffuse large B-cell lymphoma presenting as transverse myelitis. Am J Med Sci 2018;356:561-566. https://doi.org/10.1016/j.amjms.2018.09.009
  13. Kim H, Nam TS, Levy M, Lee KH, Kim J, Lee SJ. Primary central nervous system lymphoma with intramedullary spinal cord involvement mimicking inflammatory demyelinating disease. J Neurocrit Care 2019;12:55-63. https://doi.org/10.18700/jnc.190083